Literature DB >> 3531203

Secretory granules of heparin-containing rat serosal mast cells also possess highly sulfated chondroitin sulfate proteoglycans.

H R Katz, K F Austen, B Caterson, R L Stevens.   

Abstract

Rat serosal mast cells, which synthesize only heparin proteoglycans as detected by intrinsic labeling with [35S]sulfate, were analyzed for the presence of intracellular chondroitin sulfate proteoglycans by chemical and immunochemical means. Rat serosal mast cells of greater than 99% purity were treated with Zwittergent 3-12 and 4 M guanidine HCl, and the extracted nonradiolabeled proteoglycans were purified by density gradient centrifugation. As assessed by quantification of the unsaturated disaccharides released from the proteoglycans by chondroitinase ABC treatment, 10(6) rat serosal mast cells contained 2.4-4.5 micrograms of chondroitin sulfate proteoglycans. Analysis of the chondroitinase ABC digests by high performance liquid chromatography revealed the unsaturated disaccharides delta Di-4S, delta Di-diSB, and delta Di-diSE which were derived from GlcA----GalNAc-4-SO4, iduronic acid-2-SO4----GalNAc-4-SO4, and GlcA----GalNAc-4,6-diSO4, respectively. The molar ratio of the monosulfated to disulfated disaccharides was approximately 2:1 with delta Di-diSE greater than delta Di-diSB. When analyzed with a mouse anti-chondroitin sulfate monoclonal antibody and fluorescein-labeled F(ab')2 goat anti-mouse IgG, approximately 91% of permeabilized and chondroitinase ABC-treated cells in the mast cell preparations exhibited intracellular fluorescence, and the pattern of staining indicated that the chondroitin sulfate molecules were located in the secretory granules. The specificity of the monoclonal antibody for the unsaturated double bond created by chondroitinase ABC treatment of the proteoglycan in situ was established by the absence of fluorescence when the chondroitinase ABC step was omitted or when heparinase digestion was substituted for chondroitinase ABC. Furthermore, the ability of the anti-chondroitin sulfate monoclonal antibody to mediate fluorescence in situ was markedly reduced by absorption with solid-phase chondroitin sulfate proteoglycan that had been chondroitinase ABC-treated, but not by absorption with undigested proteoglycan or with solid-phase heparin. The highly sulfated chondroitin sulfate proteoglycans of rat serosal mast cells are the same type synthesized by the rat mucosal mast cell subclass.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3531203

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Mast cells.

Authors:  J S Marshall; J Bienenstock
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Mice deficient in N-acetylgalactosamine 4-sulfate 6-o-sulfotransferase are unable to synthesize chondroitin/dermatan sulfate containing N-acetylgalactosamine 4,6-bissulfate residues and exhibit decreased protease activity in bone marrow-derived mast cells.

Authors:  Shiori Ohtake-Niimi; Sachiko Kondo; Tatsuro Ito; Saori Kakehi; Tadayuki Ohta; Hiroko Habuchi; Koji Kimata; Osami Habuchi
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

3.  Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing.

Authors:  Moonsun Jung; Megan S Lord; Bill Cheng; J Guy Lyons; Hatem Alkhouri; J Margaret Hughes; Simon J McCarthy; Renato V Iozzo; John M Whitelock
Journal:  J Biol Chem       Date:  2012-12-12       Impact factor: 5.157

4.  Lectin histochemistry of the mast cell: a light microscopical study.

Authors:  C J Kirkpatrick; C J Jones; R W Stoddart
Journal:  Histochem J       Date:  1988-03

5.  3T3 fibroblasts induce cloned interleukin 3-dependent mouse mast cells to resemble connective tissue mast cells in granular constituency.

Authors:  E T Dayton; P Pharr; M Ogawa; W E Serafin; K F Austen; F Levi-Schaffer; R L Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  Phenotypic expression of mast cell granule proteinases. Distribution of mast cell proteinases I and II in the rat digestive system.

Authors:  S Gibson; A Mackeller; G F Newlands; H R Miller
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

7.  An ultrastructural study of the morphology and lectin-binding properties of human mast cell granules.

Authors:  C J Jones; C J Kirkpatrick; R W Stoddart
Journal:  Histochem J       Date:  1988-08

8.  Bioengineering murine mastocytoma cells to produce anticoagulant heparin.

Authors:  Leyla Gasimli; Charles A Glass; Payel Datta; Bo Yang; Guoyun Li; Trent R Gemmill; Jong Youn Baik; Susan T Sharfstein; Jeffrey D Esko; Robert J Linhardt
Journal:  Glycobiology       Date:  2013-12-09       Impact factor: 4.313

9.  Inhibition of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase by beta-D-4-O-sulfo-N-acetylgalactosaminides bearing various hydrophobic aglycons.

Authors:  Hiroko Nozaki; Yuri Tomoyama; Hideyuki Takagi; Koutaro Yokoyama; Chika Yamada; Ken-ichi Kaio; Masaki Tsukimori; Kazuya Nagao; Yuya Itakura; Shiori Ohtake-Niimi; Hirofumi Nakano; Osami Habuchi
Journal:  Glycoconj J       Date:  2009-12-18       Impact factor: 2.916

10.  Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice.

Authors:  Donna S Woulfe; Joanne Klimas Lilliendahl; Shelley August; Lubica Rauova; M Anna Kowalska; Magnus Abrink; Gunnar Pejler; James G White; Barbara P Schick
Journal:  Blood       Date:  2007-12-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.